MedPath

Vitamin K2 and Muscle Weakness in Type 2 Diabetes

Not Applicable
Recruiting
Conditions
Diabete Type 2
Registration Number
NCT05375630
Lead Sponsor
Dasman Diabetes Institute
Brief Summary

The aim of the current study is to determine the effects of vitamin K2 supplementation on muscle size and function in adults with muscle weakness and type 2 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Physician confirmed type 2 diabetes.
  • Age >/= 40 years
  • No changes in anti-diabetic medication in the last 3 months.
  • Muscle weakness (grip strength <27kg and females <16kg)
Exclusion Criteria
  • BMI of 45 or higher
  • BP of 160/100mmHg or higher
  • Cancer or cancer that has been in remission <5 years
  • Any medical condition that prevents participants from exercising safely
  • On anticoagulant therapy
  • Currently consuming vitamin K2 supplements
  • Current smoker

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Grip StrengthBaseline to one year

Change in Grip Strength

Secondary Outcome Measures
NameTimeMethod
Lean MassBaseline to one year

Change in lean mass

BMDBaseline to one year

Change in bone mineral density

HbA1cBaseline to one year

Change in glycated haemoglobin

Vitamin K statusBaseline to one year

Change in vitamin K status

Blood PressureBaseline to one year

Change in blood pressure

BMCBaseline to one year

Change in bone mineral content

Body MassBaseline to one year

Change in body mass

SPPBBaseline to one year

Change in Short Performance Physical Battery Test

Body FatBaseline to one year

Change in body fat

Trial Locations

Locations (1)

Dasman Diabetes Institute

🇰🇼

Kuwait City, Kuwait

Dasman Diabetes Institute
🇰🇼Kuwait City, Kuwait
Ebaa AlOZairi
Contact
Ebaa AlOzairi
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.